DUBLIN--(BUSINESS WIRE)--The "Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES, PVDF), Pore Size (0.2 Microns), End-user (Pharmaceutical, Biotechnology, F&B) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global sterile filtration market is projected to grow from USD 4.7 billion in 2019 to USD 7.4 billion by 2025, at a CAGR of 8% from 2019 to 2025.
The major factors driving the growth of this market include the advantages of sterile filters over non-sterile filters, the growing demand for pure water in end-use industries, increasing adoption of single-use devices & disposables, and the rising focus on the development of large-molecule biopharmaceutical drugs. However, the high price sensitivity among end users is a major challenge for the growth of this market.
The sterile filtration market comprises major players such as Merck KGaA (Germany), Danaher Corp. (US), Sartorius AG (Germany), 3M (US), and Parker Hannifin Corp. (US). The study includes an in-depth competitive analysis of these key players, along with their company profiles, recent developments, and key market strategies.
The capsule filter segment is expected to grow at the highest CAGR during the forecast period.
On the basis of product, the market is broadly segmented into cartridge filters, capsule filters, membranes, syringe filters, bottle-top & table-top filtration systems, and accessories. The capsule filters segment is projected to grow at the highest CAGR during the forecast period.
The growing adoption of ready-to-use capsule filters in the pharmaceutical & biopharmaceutical industry is mainly due to their advantages over stainless steel, such as high accuracy, no membrane fouling, and minimized cross-contamination. In addition to this, the availability of these filters in a variety of polymers, pore sizes, diameters, and surface types for site-specific applications is also supporting the growth of this market.
0.2-0.22 m is expected to grow at the highest CAGR during the forecast period.
Based on membrane pore size, the market is segmented into 0.2-0.22 m, 0.45 m, and 0.1 m. The 0.2-0.22 m segment is expected to be the fastest-growing, as 0.2-0.22 m filters are recommended for a wide range of pharmaceutical and biological liquid applications, including the filtration of therapeutics, vaccines, antibiotics, blood fractionations, bulk pharmaceuticals, and other downstream biotechnology processing solutions, where protein binding must be minimized.
Asia Pacific to account for the largest share of the global market during the forecast period.
Asia Pacific is expected to be the fastest-growing segment during the forecast period. Factors such as the increasing demand for generic drugs and biosimilars, significant investments by biopharmaceutical companies and CMOs in emerging Asia Pacific countries, the increasing focus on healthcare modernization, and demand for low-cost medicines are supporting the growth of the Asia Pacific market.
- Advantages of Sterile Filters Over Non-Sterile Filters
- Growing Demand for Pure Water in End-use Industries
- Focus on Developing Large-Molecule Biopharmaceutical Drugs
- Increasing Adoption of Single-Use Devices & Disposables
- Development and Use of Advanced Filters for Sterile Filtration
- Emerging Regions
- High Price Sensitivity Among End-users
- Merck KGaA
- Danaher Corporation
- Sartorius AG
- GE Healthcare
- Thermo Fisher Scientific
- Parker Hannifin Corporation
- Porvair Filtration Group
- Alfa Laval Corporate AB
- Sterlitech Corporation
- Meissner Filtration Products Inc.
- Donaldson Company Inc.
- Corning Incorporated
- Eaton Corporation
- Cole-Parmer Instrument Company, LLC
- GVS S.p.A.
- Filtration Group Process Systems - Amafilter - LFC Lochem
- Amazon Filters Ltd.
- AMD Manufacturing Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mzh1nn